Owner Alkermes Controlled Therapeutics Inc. II

Inventors Rickey, Michael, E.; Ramstack, J., Michael; Kumar, Rajesh

Agent Peter Maxwell & Associates

Pub. Number AU-B-2002324780

PCT Number PCT/US02/26953

PCT Pub. Number WO2003/020245

Priority 09/942,631 31.08.01 US

Filing date 26 August 2002

Wipo publication date 18 March 2003

Acceptance publication date 3 May 2007

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

B01J 13/08 (2006.01) Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for

B01J 13/12 (2006.01) Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for

B01J 13/20 (2006.01) Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for - After-treatment of capsule walls, e.g. hardening